Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.

Licastro F, Chiappelli M, Grimaldi LM, Morgan K, Kalsheker N, Calabrese E, Ritchie A, Porcellini E, Salani G, Franceschi M, Canal N.

Neurobiol Aging. 2005 Apr;26(4):449-53.

PMID:
15653173
2.

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

Licastro F, Pedrini S, Govoni M, Pession A, Ferri C, Annoni G, Casadei V, Veglia F, Bertolini S, Grimaldi LM.

Neurosci Lett. 1999 Aug 6;270(3):129-32.

PMID:
10462111
3.

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST.

Nat Genet. 1995 Aug;10(4):486-8. Erratum in: Nat Genet 1995 Sep;11(1):104.

PMID:
7670501
4.

APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.

Barabash A, Marcos A, Ancín I, Vázquez-Alvarez B, de Ugarte C, Gil P, Fernández C, Encinas M, López-Ibor JJ, Cabranes JA.

Neurobiol Aging. 2009 Aug;30(8):1254-64. Epub 2007 Dec 19.

PMID:
18078695
5.

Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.

DeKosky ST, Aston CE, Kamboh MI.

Ann N Y Acad Sci. 1996 Dec 16;802:27-34.

PMID:
8993481
6.

alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.

Licastro F, Chiappelli M, Thal LJ, Masliah E.

Arch Gerontol Geriatr Suppl. 2004;(9):243-51.

PMID:
15207421
7.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
8.

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T.

Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74.

PMID:
9850873
9.

Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.

Porcellini E, Davis EJ, Chiappelli M, Ianni E, Di Stefano G, Forti P, Ravaglia G, Licastro F.

Curr Pharm Des. 2008;14(26):2659-64.

PMID:
18991685
10.

No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.

Fallin D, Reading S, Schinka J, Hoyne J, Scibelli P, Gold M, Crawford F, Mullan M.

Am J Med Genet. 1997 Apr 18;74(2):192-4.

PMID:
9129722
11.

No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.

Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, Han SH, Woo JI.

Am J Med Genet. 2000 Apr 24;91(5):355-8.

PMID:
10766998
12.

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.

Murphy GM Jr, Sullivan EV, Gallagher-Thompson D, Thompson LW, van Duijn CM, Forno LS, Ellis WG, Jagust WJ, Yesavage J, Tinklenberg JR.

Neurology. 1997 May;48(5):1313-6.

PMID:
9153464
13.

No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.

Helisalmi S, Mannermaa A, Lehtovirta M, Ryynänen M, Riekkinen P Sr, Soininen H.

Neurosci Lett. 1997 Aug 1;231(1):56-8.

PMID:
9280167
14.

Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease.

Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, Xuereb J, Wischik C, Harrington C, Kalsheker NA.

Hum Genet. 1997 Jan;99(1):27-31.

PMID:
9003488
15.

Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.

Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H, Shoji S.

J Neurol Sci. 1997 Nov 25;152(2):136-9.

PMID:
9415533
16.

Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.

Scacchi R, Ruggeri M, Gambina G, Martini MC, Ferrari G, Corbo RM.

Neurobiol Aging. 2001 May-Jun;22(3):413-6.

PMID:
11378247
17.

Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.

Panza F, Solfrizzi V, Torres F, Mastroianni F, Colacicco AM, Basile AM, Capurso C, D'Introno A, Del Parigi A, Capurso A.

Neurosci Lett. 2000 Oct 6;292(2):79-82.

PMID:
10998553
18.

Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism.

Yamamoto M, Kondo I, Ogawa N, Asanuma M, Yamashita Y, Mizuno Y.

Brain Res. 1997 Jun 6;759(1):153-5.

PMID:
9219874
19.

Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.

Ezquerra M, Blesa R, Tolosa E, Ballesta F, Oliva R.

Neurosci Lett. 1998 Jan 9;240(2):107-9.

PMID:
9486483
20.

The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.

Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Luna JL.

Neurosci Lett. 2001 May 25;304(3):204-8.

PMID:
11343837

Supplemental Content

Support Center